The course runs over 13 weeks. The emphasis is on multimodality patient care which offers the best chance for a favorable outcome for a variety of common tumor types including breast, colorectal, prostate, gastroesophageal junction and melanoma. The unit is designed to address each cancer type with an overview highlighting those issues of importance when discussing management at an MDT meeting including: anatomical pathology description of the tumor, clinicopathological staging, pathology, advances in Molecular Biology, Imaging, Surgery, Radiation and Medical oncology, new biologic therapies and the place of palliation of advanced disease. The emphasis is largely on self- directed learning with online lectures and reading material provided by a Faculty of clinicians drawn from various metropolitan teaching hospitals. Specific Learning objectives: 1) to develop the skills to advocate evidence based management for the individual needs of a patient in an MDT meeting and to understand the contribution of each clinical discipline in the decision-making process 2) to demonstrate an adequate background knowledge of the natural history and classification of common tumors 3) to formulate a cancer specific management plan based on standardised reporting of the extent of tumour burden 4) to understand the influence of evidencebased, independent prognostic factors on outcomes and evolving concepts in cancer biology.
Unit details and rules
Unit code | SURG5041 |
---|---|
Academic unit | Surgery |
Credit points | 6 |
Prohibitions
?
|
None |
Prerequisites
?
|
None |
Corequisites
?
|
None |
Assumed knowledge
?
|
Candidates are expected generally to be undertaking advanced surgical training or similar. Senior clinicians can request special permission to enroll without needing to complete pre-requisite PATH5000. |
Available to study abroad and exchange students | No |
Teaching staff
Coordinator | Brett Hambly, brett.hambly@sydney.edu.au |
---|